Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
EPIC: NVO
Market: NYSE
52-week High/Low: $52.88 / $32.84
Sector: Pharmaceuticals
Market Cap: $129,253.00M
Novo Nordisk

Novo Nordisk

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Novo Nordisk

www.novonordisk.com

Interactive graph

col 3
col 4
col 5
col 6

Novo Nordisk Timeline

Columns Including NVO

VIEW ALL

Market Reports Including NVO

VIEW ALL

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use